Lv3
342 积分 2023-03-22 加入
Best Practices for Use-Related Risk Analysis Through Collaboration of Human Factors and Clinical
18小时前
已完结
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
1个月前
已完结
Technical Report No. 73-2: Application of Medical Device Regulation Annex 1 Requirements for Staked Needle Syringes
2个月前
已完结
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
4个月前
已完结
The Drug-Dosing Conundrum in Oncology — When Less Is More
5个月前
已完结
Dosing immune-checkpoint inhibitors: Opportunities for the future
5个月前
已完结
Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab
5个月前
已完结
Selecting an Optimal Antibody for Antibody- Drug Conjugate Therapy
6个月前
已完结
Recent advances in large-scale production of monoclonal antibodies and related proteins
9个月前
已完结
Industry Perspective on the use and Characterization of Polysorbates for Biopharmaceutical Products Part 1: Survey Report on Current State and Common Practices for Handling and Control of Polysorbates
11个月前
已完结
皖公网安备34019202002308
